Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery

Trial Profile

Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Sep 2016

At a glance

  • Drugs Moxifloxacin (Primary) ; Triamcinolone (Primary) ; Vancomycin (Primary) ; Ketorolac; Prednisolone
  • Indications Postoperative infections; Postoperative inflammation
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top